Magna

Magna is a New York-based investment firm founded in 2009 by Josh Sason. The firm specializes in mid-market and special situation investments, primarily focusing on small and lower middle market companies in the technology and healthcare sectors. Additionally, Magna invests in entertainment properties, including film, television, music, and events. By leveraging its capital, time, and strategic expertise, Magna aims to build successful, long-term relationships with its portfolio companies across various industries.

Ari Morris

Managing Director

Ari Sason

Managing Director

6 past transactions

Uhnder

Series D in 2024
Uhnder Inc. is a technology company that specializes in developing innovative products for sensing, cognition, and communication within the Internet of Things (IoT) market. Founded in 2015 and headquartered in Austin, Texas, with additional engineering and operations in St. Louis, Uhnder is recognized for its digital automotive radar-on-chip. This technology serves as a more accurate and reliable alternative to traditional light detection and ranging (lidar) systems, enhancing the safety and responsiveness of autonomous vehicles. The chip is designed to prevent collisions, alert drivers to potential hazards, and facilitate quick localization for navigation. By offering this advanced solution, Uhnder aims to significantly improve the automation capabilities of manufacturers in the automotive sector.

Uhnder

Series C in 2020
Uhnder Inc. is a technology company that specializes in developing innovative products for sensing, cognition, and communication within the Internet of Things (IoT) market. Founded in 2015 and headquartered in Austin, Texas, with additional engineering and operations in St. Louis, Uhnder is recognized for its digital automotive radar-on-chip. This technology serves as a more accurate and reliable alternative to traditional light detection and ranging (lidar) systems, enhancing the safety and responsiveness of autonomous vehicles. The chip is designed to prevent collisions, alert drivers to potential hazards, and facilitate quick localization for navigation. By offering this advanced solution, Uhnder aims to significantly improve the automation capabilities of manufacturers in the automotive sector.

Frontier Diamonds

Post in 2018
Frontier Diamonds Limited is involved in diamond exploration and development in South Africa, holding a 74% interest in the Sedibeng diamond mine and a 100% interest in the Star diamond mine. The Sedibeng mine, located in the Northern Cape, consists of two licenses covering 89.62 hectares, while the Star mine, situated in the Free State, encompasses a single license over 246.29 hectares. Established in 2016 and based in Melbourne, Australia, Frontier Diamonds focuses on optimizing operations and enhancing efficiency at these mines, which have shown profitability and positive cash flow over the past two years. The company aims to leverage its expertise in engineering and underground mining to improve productivity and is exploring additional opportunities to expand its footprint in the diamond industry. With both mines expected to sustain operations for at least 15 years, Frontier Diamonds is positioned to become a significant producer of high-quality diamonds.

Zubie

Venture Round in 2016
Zubie is a connected vehicle services company that offers a platform designed to deliver essential vehicle health, location, and safety information to both consumers and businesses. By utilizing a simple plug-in device known as the Zubie Key, users can effortlessly monitor critical vehicle data, such as fuel efficiency and driving behavior, via mobile applications for iOS and Android, as well as an online web portal. This service not only helps individual consumers keep track of their vehicles but also provides businesses with a low-cost fleet management solution aimed at enhancing vehicle maintenance, preventing accidents, and optimizing fleet operations.

Bioheart

Post in 2014
Bioheart, Inc. is dedicated to advancing the field of regenerative medicine by offering the highest quality technology, cellular treatments and training. Specific to biotechnology, Bioheart, Inc. specializes in the discovery, development and commercialization of autologous cellular therapies that treat a wide variety of degenerative diseases. Bioheart, Inc. is committed to maintaining its leading position within the cardiovascular sector of the cell technology industry by delivering stem cell therapies and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions, chronic and acute heart damage, peripheral vascular disease and other issues. Bioheart's goals are to improve a patient’s quality of life by regenerating their damaged tissue, when possible, and by reducing health care costs and hospitalizations. Bioheart’s leading product, MyoCell, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.

SINTX Technologies

Post in 2014
SINTX Technologies is a ceramics company focused on silicon nitride for medical and related applications. It develops and manufactures silicon nitride biomaterials used in implants and devices, with products designed to be biocompatible, bioactive, antipathogenic, and to have good bone affinity. The company produces silicon nitride spinal implants in an ISO 13485 certified facility for CTL-Amedica, its exclusive retail channel for such implants, and markets products through direct sales, distributors, OEM partnerships, and private-label arrangements. Founded in 1996 and headquartered in Salt Lake City, it serves customers in the United States, Europe, and South America.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.